文獻： 1、" Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature. " Pharmacotherapy 2007;27:290–8. Page RL, Schwiesow J, Hilts A. 2、Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol 2013;39:310–24. Vehreschild JJ, Birtel A, Vehreschild MJGT, et al. 3、Tarantino MD, Fogarty P, Mayer B, Vasey SY, Brainsky A. Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia. Blood Coagul Fibrinolysis. 2013 Apr;24(3):284-96. doi: 10.1097/MBC.0b013e32835fac99. 4、J Med Chem, 51: 4632～4640. Org. Process Res. Dev. 2019, 23, 9, 2057-2068 Pharmazie 73(9):494-497 · September 2018 5、中國醫藥工業雜志 2012， 43（8）， 644-646 6、精細化工中間體2013，43（2），46-48 7、精細化工中間體2011，41（4），46-48 8、中國現代應用藥學2011，28（1），58-59 9、Chemical biology&Drug Design 2014, 83(3), 306-316 10、Letters in organic chemistry 2012, 9(4), 276-279 11、Medicines Evidence Commentary : Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders Source: National Institute for Health and Care Excellence - NICE - 21 January 2014 - Publisher: National Institute for Health and Care Excellence (NICE) 12、double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children 13、J. Med. Chem. 2018, 61, 5304?5322. 14、Chem. Biol. Drug Des. 2014, 83, 306?316. 15、J. Pharm. Biomed. Anal. 2009, 50, 144?150. 16、Int. J. Pharm. Sci. 2016, 8, 97?102. 17、J. Pharm. Biomed. Anal. 2010, 52, 493?507. 18、Org. Process Res. Dev. 2013, 17, 1036?1041. 19、Beilstein J. Org. Chem. 2011, 7, 442? 495. 20、Bioorg. Med. Chem. Lett. 2014, 24, 1108?1110. 21、New Activated PEG Derivatives for Affinity Partitioning 22、Population incidence and mortality of sepsis in an urban African setting 2013-2016 23、Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income Countries 24、In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis J. G. Bueno C. Martinez B. Zapata G. Sanclemente M. Gallego A. C. Mesa First published: 02 July 2010 25、Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004;350:951–2. Marty FM, Cosimi LA, Baden LR. 26、Alterations in L-Histidine Transport in-Rsponse to Aspirin- and Nimesulide- Induced Toxicity in Rat Intestine Using Everted Intestinal Sacs. 27、Drug interactions with nimesulide. 28、Action of Some Steroids on the Central Nervous System of the Mouse. I. Synthetic Methods 29、Scand J Clin Lab Invest. 2001 Apr;61(2):89-94. Bioelectric impedance analysis of acute body water changes in congestive heart failure 30、Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations. Clin Pharmacokinet. 2005;44(2):211-20. Ezzet F1, Wexler D, Courtney R, Krishna G, Lim J, Laughlin M. 31、Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations. Clin Pharmacokinet. 2011 Nov 1;50(11):725-34. Walravens J1, Brouwers J, Spriet I, Tack J, Annaert P, Augustijns P. 32、Determination of ornidazole and its main metabolites in biological fluids Author ： overlay panelP.HeizmannR.GeschkeK.Zinapold Journal of Chromatography B: Biomedical Sciences and Applications Volume 534, 1990, Pages 233-240 33、Metabolic Studies of Ornidazole in the Rat, in the Dog and in Man D. E. Schwartz, J.-C. Jordan, W. Vetter & G. Oesterhelt Pages 571-581 | Received 14 Nov 1978, Published online: 30 Sep 2009 Journal Xenobiotica the fate of foreign compounds in biological systems Volume 9, 1979 - Issue 9 34、Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors 35、A novel oral capsule can deploy microneedle patches that release drugs into the intestinal wall for uptake into the bloodstream as shown in animal studies, thereby avoiding injections.patch drug delivery in the gut 36、Cyanocobalamin degradation Stanley Scheindlin First published: August 1976 37、Preparation of Polytosylated γ-Cyclodextrins Yamamura, Hatsuo; Kawase, Yoshitaka; Kawai, Masao; Butsugan, Yasuo [Bulletin of the Chemical Society of Japan, 1993, vol. 66, # 2, p. 585 - 588] 38、ＴＥＮＮＥＲＳ，ＢＡＩＬＬＩＥＪ，ＤEＷＩＴＴＪ，ｅｔａｌ．ＡｍｅｒｉｃａｎＣｏｌｌｅｇｅｏｆＧａｓｔｒｏｅｎｔｅｒｏｌｏｇｙｇｕｉｄｅｌｉｎｅ：ｍａｎａｇｅｍｅｎｔｏｆａｃｕｔｅｐａｎｃｒｅａｔｉｔｉｓ［Ｊ］．ＡｍＪＧａｓｔｒｏｅｎｔｅｒｏｌ，２０１３，１０８（９）：１４００－１４１５，１４１ 藥典（EP10）： 1、昔萘酸沙美特羅Salmeterol Xinafoate 2、氨基水楊酸鈉Sodium Aminosalicylate Dihydrate 3、亞胺培南Imipenem monohydrate 4、西司他丁鈉Cilastatin sodium、 5、制霉菌素Nystatin 6、ω-3 脂肪酸甘油三酯Omega-3-Acid Triglycerides 7、噻托溴銨一水合物Tiotropium Bromide Monohydrate 8、硫酸沙丁胺醇Sulbutamol Sulphate 9、Tigecycline EP10.0標準 10、1. 5.4. Residual solvents 11、2. 5.10. Control of impurities in substances for pharmaceutical use 12、Substances for pharmaceutical use (2034) 13、Sitagliptin phosphate monohydrate的EP10.0 14、Losartan potassium 15、valsartan 16、ZolmitriptanEP10.0 17、Cefapirin sodium EP10 18、SODIUM IODIDE (131I) CAPSULES EP10.0 19、磷酸氟達拉濱Fludarabine Phosphate 20、EP10.0的地氯雷他定desloratadine 21、Valproic acid 22、Sodium valproate 23、Minoxidil 24、Quetiapine fumarate 25、Quetiapine fumarate 26、Metoclopramide Hydrochloride